INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
INTENSITY THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.29−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- $8.90M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Intensity Therapeutics has not reported a dividend
No dividend per share appears in Intensity Therapeutics's annual filings since fiscal 2021.